The Michael J. Fox Foundation (MJFF), dedicated to finding a cure for Parkinson’s disease, has granted Portuguese researchers, Carlos Palmeira and Rodrigo Cunha, the “Rapid Response Innovation Award.”
Both researchers are affiliated with the Center for Neurosciences and Cell Biology at the University of Coimbra, Portugal.
Carlos Palmeira is an Associate Professor in the Department of Life Sciences and a research scientist at the Center for Neurosciences and Cell Biology of the University of Coimbra. A member of several international societies, he is author and co-author of more than 70 papers. He received his PhD in Biochemistry from the University of Coimbra and did a postdoctoral training in biochemical toxicolog at the University of Minnesota, USA.
Rodrigo Cunha is an Associate Professor and researcher at the Faculty of Medicine and director of the Department of Neuropharmacology of the Center for Neurosciences of the University of Coimbra. He has published over 130 papers and is also a member of Steering Committee of the European Neuroscience Campus (ENC, first European PhD program in neurosciences) and European Neuroscience Institute Network (ENI-Net). He holds a PhD in Biochemistry (Pharmacology) from the University of Lisbon, Portugal.
Established in 2000, by Canadian screen actor Michael J. Fox, who was diagnosed with young-onset Parkinson’s disease in 1991, the Michael J. Fox Foundation for Parkinson’s Research supports novel Parkinson’s disease related research in real-time through innovative research focused on the cause of and cure of the disease. The Foundation has become the largest private funder of Parkinson’s disease research in the world, investing nearly $285 million in research to date.
The University of Coimbra, founded in 1290 by Portuguese King D. Dinis (1261-1325), is the oldest university of Portugal, one of the oldest universities in Europe and the world and one of largest higher education Portuguese research institutions.
For donations click here >>
paj.cm